Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-14

Clinical Trial Update: A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) [NA]

View source ↗

Summary

Clinical trial update for the ABSORB CHINA randomized controlled trial evaluating the Absorb Bioresorbable Vascular Scaffold in a Chinese population; completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Absorb™ Bioresorbable Vascular Scaffold System (bioresorbable vascular scaffold)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease, Coronary Artery Stenosis | NA | Status: COMPLETED | Results posted: 2018-02-14